Oral administration of mTOR inhibitors in UVB-induced mouse models has been effective in reducing the number and size of AK and cSCC lesions, indicating their potential in both treatment and prevention of these conditions (202). The gene discussed is MTOR; the disease is skin squamous cell carcinoma.